WuXi AppTecâ€™s Laboratory Testing Division is a comprehensive and integrated testing platform for drug and medical device development. Fully integrated within WuXi AppTec, a world-class CRO with operations in China and the US, the Laboratory Testing Division provides in vivo and in vitro assays from early screening through clinical sample analysis, and medical device testing from development through product lifecycle management. We operate with full transparency, providing the high-quality data you need to advance your project while meeting international standards for regulatory compliance and maintaining industry-leading turnaround times. The Laboratory Testing Division consists of three integrated testing platformsâ€”WuXi AppTec IND (WIND) for Preclinical Drug Development; Clinical Drug Development; and Medical Device Testing. Each platform is supported by the complementary capabilities of our four service units, which include Analytical, Bioanalytical, Toxicology and DMPK services. Testing services are offered as a comprehensive package in support of global IND/NDA filings, or on a standalone basis, with customized study designs available to meet the varying needs of our diverse client base.
Offices in China:
R&D Facility for Analytical, Bioanalytical & DMPK Services 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai (P.C.200131) China
R&D Facility for DMPK & Bioanalytical No.1 Hengfei Road Economic & Technological Development Zone Nanjing (P.C.210038) China
R&D Facility for DMPK, Toxicology, Bioanalytical & Medical Device Services 1318 Wuzhong Avenue Wuzhong District Suzhou (P.C.215104) China